Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platelets from patients with myocardial infarction can activate T cells.
Solomou EE, Katsanaki K, Kalyvioti E, Gizas V, Perperis A, Babali D, Verigou E, Gogos H, Hahalis G, Davlouros P, Alexopoulos D. Solomou EE, et al. Among authors: perperis a. Haematologica. 2021 Jan 1;106(1):288-290. doi: 10.3324/haematol.2019.243402. Haematologica. 2021. PMID: 32107333 Free PMC article. No abstract available.
Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI.
Alexopoulos D, Gkizas V, Patsilinakos S, Xanthopoulou I, Angelidis C, Anthopoulos P, Makris G, Perperis A, Karanikas S, Koutsogiannis N, Davlouros P, Deftereos S, Chiladakis J, Hahalis G. Alexopoulos D, et al. Among authors: perperis a. J Am Coll Cardiol. 2013 Sep 3;62(10):940-1. doi: 10.1016/j.jacc.2013.05.021. Epub 2013 Jun 7. J Am Coll Cardiol. 2013. PMID: 23747780 Free article. Clinical Trial. No abstract available.
Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study.
Alexopoulos D, Makris G, Xanthopoulou I, Patsilinakos S, Deftereos S, Gkizas V, Perperis A, Karanikas S, Angelidis C, Tsigkas G, Koutsogiannis N, Hahalis G, Davlouros P. Alexopoulos D, et al. Among authors: perperis a. Circ Cardiovasc Interv. 2014 Apr;7(2):233-9. doi: 10.1161/CIRCINTERVENTIONS.113.001118. Epub 2014 Mar 25. Circ Cardiovasc Interv. 2014. PMID: 24668226 Clinical Trial.
Ticagrelor versus high dose clopidogrel in ST-segment elevation myocardial infarction patients with high platelet reactivity post fibrinolysis.
Alexopoulos D, Perperis A, Koniari I, Karvounis H, Patsilinakos S, Ziakas A, Barampoutis N, Panagiotidis T, Akinosoglou K, Hahalis G, Xanthopoulou I. Alexopoulos D, et al. Among authors: perperis a. J Thromb Thrombolysis. 2015 Oct;40(3):261-7. doi: 10.1007/s11239-015-1183-9. J Thromb Thrombolysis. 2015. PMID: 25680893 Clinical Trial.
Dyspnea in patients treated with P2Y12 receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registry.
Alexopoulos D, Xanthopoulou I, Perperis A, Goudevenos J, Hamilos M, Sitafidis G, Kanakakis I, Vavouranakis M, Giannopoulos G, Barampoutis N, Deftereos S, Lekakis J. Alexopoulos D, et al. Among authors: perperis a. Platelets. 2017 Nov;28(7):691-697. doi: 10.1080/09537104.2016.1265919. Epub 2017 Feb 2. Platelets. 2017. PMID: 28150522 Free article.
23 results